Association of Genetic Polymorphisms of Endothelin-Converting Enzyme-1 Gene with Hypertension in a Japanese Population and Rare Missense Mutation in Preproendothelin-1 in Japanese Hypertensives

Abstract

Endothelin-1 (EDN1), a 21-amino acid peptide, is a potent vasoconstrictor with various pharmacological responses. EDN1 is synthesized from a 212-amino acid precursor protein, preproEDN1, through multiple proteolytic steps. Endothelin-converting enzyme (ECE) cleaves a Trp73−Val74 peptide bond in big-EDN1 to give rise to mature EDN1. In this study, we examined the possible association of genetic variations in ECE1 with hypertension in a general Japanese population and searched for missense mutations in and around the EDN1 polypeptide. We genotyped 5 single nucleotide polymorphisms (SNPs) in the ECE1 gene in 1,873 individuals from a general Japanese population and identified one SNP associated with hypertension in women (rs212528: TT vs. TC+CC: odds ratio=1.40; 95% confidence intervals: 1.04–1.89; p=0.026), after adjusting for confounding factors. The systolic blood pressure in women with the CC genotype was 6.44 mmHg higher than that in those with the TT genotype (p=0.007), after adjusting for the same factors. Next, to identify the missense mutations that may influence the biological activity of EDN1, we sequenced the genomic region that encodes EDN1 in 942 Japanese hypertensive patients. We identified a novel missense mutation, G36R, in one hypertensive patient, but no mutations were observed in EDN1. A gene polymorphism in EDN1, Lys198Asn, has been reported to be associated with hypertension in obese subjects. Taken together, these findings reveal that the EDN-ECE pathway is an important system involved in essential hypertension in Japanese.

References

  1. 1

    Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–415.

  2. 2

    Miyauchi T, Masaki T : Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 1999; 61: 391–415.

  3. 3

    Tiret L, Poirier O, Hallet V, et al: The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 1999; 33: 1169–1174.

  4. 4

    Asai T, Ohkubo T, Katsuya T, et al: Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 2001; 38: 1321–1324.

  5. 5

    Jin JJ, Nakura J, Wu Z, et al: Association of endothelin-1 gene variant with hypertension. Hypertension 2003; 41: 163–167.

  6. 6

    Tanaka C, Kamide K, Takiuchi S, et al: Evaluation of the Lys198Asn and −134delA genetic polymorphisms of the endothelin-1 gene. Hypertens Res 2004; 27: 367–371.

  7. 7

    Funalot B, Courbon D, Brousseau T, et al: Genes encoding endothelin-converting enzyme-1 and endothelin-1 interact to influence blood pressure in women: the EVA study. J Hypertens 2004; 22: 739–743.

  8. 8

    Funke-Kaiser H, Reichenberger F, Kopke K, et al: Differential binding of transcription factor E2F–2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation. Hum Mol Genet 2003; 12: 423–433.

  9. 9

    Risch N, Merikangas K : The future of genetic studies of complex human diseases. Science 1996; 273: 1516–1517.

  10. 10

    Collins FS, Guyer MS, Charkravarti A : Variations on a theme: cataloging human DNA sequence variation. Science 1997; 278: 1580–1581.

  11. 11

    Lander ES : The new genomics: global views of biology. Science 1996; 274: 536–539.

  12. 12

    Cohen JC, Kiss RS, Pertsemlidis A, et al: Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004; 305: 869–872.

  13. 13

    Frikke-Schmidt R, Nordestgaard BG, Jensen GB, et al: Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 2004; 114: 1343–1353.

  14. 14

    Kamide K, Tanaka C, Takiuchi S, et al: Six missense mutations of the epithelial sodium channel β and γ subunits in Japanese hypertensives. Hypertens Res 2004; 27: 333–338.

  15. 15

    Kamide K, Takiuchi S, Tanaka C, et al: Three novel missense mutations of WNK4, a kinase mutated in inherited hypertension, in Japanese hypertensives: implication of clinical phenotypes. Am J Hypertens 2004; 17: 446–449.

  16. 16

    Yang J, Kamide K, Kokubo Y, et al: Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population. J Hypertens 2005; 23: 1497–1505.

  17. 17

    Kamide K, Yang J, Kokubo Y, et al: A novel missense mutation, F826Y, in the mineralocorticoid receptor gene in Japanese hypertensives: implication of clinical phenotypes. Hypertens Res 2005; 28: 703–709.

  18. 18

    Vanhoutte PM, Feletou M, Taddei S : Endothelium-dependent contractions in hypertension. Br J Pharmacol 2005; 144: 449–458.

  19. 19

    Mannami T, Baba S, Ogata J : Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study. Arch Intern Med 2000; 160: 2297–2303.

  20. 20

    Kokubo Y, Inamoto N, Tomoike H, et al: Association of genetic polymorphisms of sodium-calcium exchanger 1 gene, NCX1, with hypertension in a Japanese general population. Hypertens Res 2004; 27: 697–702.

  21. 21

    Haga H, Yamada R, Ohnishi Y, et al: Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. Single-nucleotide polymorphism. J Hum Genet 2002; 47: 605–610.

  22. 22

    Hirakawa M, Tanaka T, Hashimoto Y, et al: JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res 2002; 30: 158–162.

  23. 23

    Okuda T, Fujioka Y, Kamide K, et al: Verification of 525 coding SNPs in 179 hypertension candidate genes in the Japanese population: identification of 159 SNPs in 93 genes. J Hum Genet 2002; 47: 387–394.

  24. 24

    Matayoshi T, Kamide K, Takiuchi S, et al: The thiazide-sensitive Na+-Cl cotransporter gene, C1784T, and adrenergic receptor-β3 gene, T727C, may be gene polymorphisms susceptible to the antihypertensive effect of thiazide diuretics. Hypertens Res 2004; 27: 821–833.

  25. 25

    Kokubo Y, Kamide K, Inamoto N, et al: Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population. J Hum Genet 2004; 49: 507–515.

  26. 26

    Webb CM, Ghatei MA, McNeill JG, et al: 17β-Estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation 2000; 102: 1617–1622.

  27. 27

    Rodrigo MC, Martin DS, Eyster KM : Vascular ECE-1 mRNA expression decreases in response to estrogens. Life Sci 2003; 73: 2973–2983.

  28. 28

    Antonarakis SE, Nomenclature Working Group: Recommendations for a nomenclature system for human gene mutations. Hum Mut 1998; 11: 1–3.

Download references

Author information

Correspondence to Kei Kamide.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Banno, M., Hanada, H., Kamide, K. et al. Association of Genetic Polymorphisms of Endothelin-Converting Enzyme-1 Gene with Hypertension in a Japanese Population and Rare Missense Mutation in Preproendothelin-1 in Japanese Hypertensives. Hypertens Res 30, 513–520 (2007). https://doi.org/10.1291/hypres.30.513

Download citation

Keywords

  • endothelin
  • endothelin-converting enzyme
  • gene variants
  • hypertension
  • general population

Further reading